Results

Total Results: 1,653 records

Showing results for "described".

101. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research-protocol.pdf
     November 16, 2010 - aspects of the framework and depicts the key questions within the context of the inclusion criteria described … The specific populations, interventions, and outcomes of interest are described in Section II. … further clarification, as appropriate, after examining the full text according to the guidelines described … Studies labeled “ include” will be further assessed for methodological quality as described in Section … risk of bias in relevant studies, as well as aspects of consistency, directness, and precision as described

102. Chronic-urinary-retention-protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
     November 19, 2012 - The PICOTS (Population, Intervention, Comparison, Outcomes, Timing, and Setting) for all KQs are described … review based on the PICOTS framework outlined in Section II and the study-specific inclusion criteria described … Investigator assessment of these items will compare reported results to planned analysis described in … trial registries and/or the methodology section of the publication as described in a recent AHRQ Methodology … etiology, narrow eligibility criteria, patient and intervention characteristics different than those described

103. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-psoriatric_research-protocol.pdf
     December 06, 2010 - Framework Figure 1: This figure depicts the key questions (KQs) within the context of the PICOTS described … The steps that we will take to accomplish the literature review are described below. … reviewed by two trained members of the team for inclusion or exclusion based on the eligibility criteria described … Our second quality rater is our senior reviewer, who as described above, completes a second full review

104. Management of Infantile Hemangioma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
     June 01, 2016 - go through growth and involution phases, although the complete natural history of IH has not been described … Overall, the role of laser therapy in treating IH lesions is not clearly described in the literature … of the Evidence Base ��Indications for treatment and treatment referral were often not clearly described

105. Disposition of Comments Report for Pressure Ulcer Risk Assessment and Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
     May 08, 2013 - As described in the cited reference to USPSTF methods, this refers to studies not having differential … Peer Reviewer #2 Executive Summary On page ES-6, the categorization of study quality is described … The limitations of the studies and of the review are adequately described. … However, as described in responses to several comments by peer reviewers, we are now including trials … As described in Appendix F and the Evidence Tables, blinding is assessed separately for patients, care

106. Dementia-Agitation-Aggression Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_executive.pdf
     March 01, 2016 - The study-specific inclusion criteria are described in Table C. … Agitation/aggression was rarely described other than in reports of instrument scores. … Details regarding the population, setting, and methodology were often inadequately described. … Control conditions were also often poorly described. … Few trials described these characteristics, so applicability is unclear.

107. Topic Brief: Interventions to Decrease Hospital Length of Stay (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-hospital-length-of-stay.pdf
     November 01, 2019 - The abstract described the frequency of outcomes across primary studies but did not present results … ROB was described in the abstract. … RoB assessment was not described in the abstract. … RoB was not described in the abstract. … ROB methods are described. Anticipated completion is November 2019.

108. Disposition of Comments for Technical Brief 36: Strategies for Patient, Family, and Caregiver Engagement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/technical-brief-36-patient-engagement-comments.pdf
     August 26, 2020 - In particular, we described the rationale for adapting the original model (by Carman and colleagues) … The “levels” of patient and family caregiver engagement are described as: direct patient care, health … Maybe these aren't described or this detail is out of scope. Then this is a limitation. … The purpose should inform the search strategy as described in methodology section below. … And the purpose needs to be consistently described throughout the manuscript.

109. Disposition of Comments for Progestogens for Prevention of Preterm Birth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
     September 07, 2012 - The statistical methods for meta-analysis is described sufficiently. Thank you. … For example, for the meis trial, the placebo is described repeatedly as castor oil, but the placebos … for other studies are not described. … The characteristics of the studies are well described and I believe that the messages come through … The strength of evidence grading system is described in detail in the Methods chapter.

110. Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
     December 16, 2014 - Study characteristics are well described. Key messages are explicit and applicable. … If it never did, this should be described as a strength. … Yes Are the limitations of the review/studies described adequately? … It is a significant undertaking - very well written, excellent methods which very well described. … We included any comparators that were described in any studies that met our inclusion criteria.

111. Disposition of Comments Report for Evidence Report/Technology Assessment No. 214 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/smoking-pregnancy-infants_disposition-comments.pdf
     February 25, 2014 - The quality was rated using the process described in the Methods section. … This review provided a de novo, objective review of the literature using the methods described in the … Reviewer 5 Results The studies are described. Thank you. … Reviewer 9 (TEP) Results The results are clearly described, the key messages explicit, the tables … We have described these characteristics as much as possible.

112. Nppv-Respiratory-Failure Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_executive.pdf
     July 01, 2012 - The TEP members provided the same range of viewpoints and expertise as are described for the KI group … In addition, we described comparators (especially supportive therapy) as carefully Table A. … We graded the strength of evidence (SOE) for each outcome assessed using the approach described in the … impede dissemination and contribute to the knowledge deficits described in surveys of clinicians. … Twelve of the 69 studies poorly described the patient population, and 9 reported only outcomes that

113. Disposition of Comments Report for Primary Care Management of Abnormal Uterine Bleeding (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
     March 21, 2013 - Peer Reviewer #6 Results The study characteristics are clearly described in the narrative, figures, … Peer Reviewer #6 General These elements are all well described in the report. … authors have incompletely described the mechanism, and what is there is incorrect. … Indeed, there are two types of cyclic administration that are described – a “luteal phase” or short … The inclusion criteria were established and described in the protocol for this review.

114. Disposition of Comments Report for Outpatient Case Management for Adults With Medical Illness and Complex Care Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_disposition-comments.pdf
     January 01, 2013 - The characteristics of the study are clearly described. … Inclusion and exclusion criteria are also described in Appendix C. … Are the characteristics of the studies clearly described? … Studies are briefly, but clearly described. … Are the limitations of the review/studies described adequately?

115. Disposition of Comments for Pulmonary Arterial Hypertension: Screening, Management, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
     April 25, 2013 - Peer Reviewer 3 Results The results are clearly described in appropraite detail. … The characteristics of the studies are clearly described. … TEP Member 7 Results The section is very detailed and clearly described. … We agree that the individual study designs are not neatly described. … described in Table 3 and grouped in categories good, fair or poor.

116. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
     March 10, 2010 - A statement, “Trials are described further in the review” has been added where they are first discussed … This is usually described as “drawing” random samples from normal distributions. … Unfortunately, they described this in various ways. … Discussion Are the limitations of the review/studies described adequately? … The adverse events seem to be described in ways that accentuate their probability.

117. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_research-protocol.pdf
     October 18, 2010 - All screening will be conducted in DistillerSR using a priori developed inclusion criteria as described … The methodology to assess ITT, loss to followup, and confounding by indication, is described in more … Loss to followup will be assessed according to the process described below. … Reasons for heterogeneity will be explored using subgroup analyses and meta- regression, as described … Sensitivity analyses will take the form of subgroup analyses as described above.

118. Dietary Total Fat Intake and Dietary Polyunsaturated Fatty Acid Intake and Child Growth and Development Outcomes: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/child-growth-development-outcomes-protocol.pdf
     August 19, 2024 - Although the scope of this review is limited to outcomes for individuals through 18 years of age , as described … We will triage abstracts using a modified review approach, described in the Study Selection section … Study Selection We will use pre-defined criteria described in Table 1 to screen citations (titles and … Studies will be rated as being “low,” “moderate,” or “high” risk of bias as described below in Table … The strength of the evidence may be downgraded based on the limitations described above.

119. Disposition of Comments: Comparative Effectiveness Review 235_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD-Repository Evidence Base (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-comments.pdf
     November 04, 2020 - TEP 5 Methods Overall the methods were comprehensive and described in a clear and standard fashion. … We have described characteristics of the High ROB studies, highlighting which domains were rated as … As described above, this phrase is commonly used in the field of PTSD, though so is PTSD diagnostic … As described in this section, these decisions were made on the recommendations of the TEP and the … Specific areas where information is more sparse and may warrant further research might be described

120. Rapid Evidence Product: No-Touch Modalities for Disinfecting Patient Rooms in Acute Care Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-no-touch-modalities.pdf
     May 01, 2022 - *Standard cleaning protocol not explicitly described. … “Cleaning phase” + Manual cleaning (0.5% sodium hypochlorite solution) *Cleaning phase only described … Interrupted time series Single center; standard cleaning procedures described and adequacy verified … Wong et al. 201617 Canada Pre/post study Single center; standard cleaning procedures described; baseline … Sifri et al. 201620 United States Pre/post study Single center, standard cleaning described, fidelity